DRTS Alpha Tau Medical Ltd. NASDAQ · United States

Alpha Tau Medical (DRTS) news

Alpha Tau Medical Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker DRTS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Alpha Tau Medical news

We have not published a story on Alpha Tau Medical yet. When there is news, it will appear here.

Alpha Tau Medical annual financials

Line	FY2025	FY2024
Research and development	$32.1 million	$27.0 million
Net income (loss)	-$42.6 million	-$31.8 million
Cash from operations	-$26.7 million	-$19.8 million
Cash and equivalents	$12.2 million	$13.7 million
Short-term investments	$60.9 million	$45.9 million

Latest balance sheet, Dec 31, 2025 (20-F): cash and equivalents $12.2 million, plus short-term investments of $60.9 million, $73.1 million in all.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Alpha Tau Medical

What is the ticker symbol of Alpha Tau Medical?

Alpha Tau Medical Ltd. trades under the ticker DRTS on NASDAQ.

Where is Alpha Tau Medical listed?

Alpha Tau Medical Ltd. is listed on NASDAQ.

Which country or territory is Alpha Tau Medical listed under?

Our directory records Alpha Tau Medical Ltd. under United States.

Does aibio.space cover Alpha Tau Medical?

aibio.space lists Alpha Tau Medical Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Is Alpha Tau Medical profitable?

Alpha Tau Medical Ltd. reported a net loss of $42.6 million for the fiscal year ended Dec 31, 2025, and used $26.7 million of cash in operations, per its annual report to the SEC.

How much does Alpha Tau Medical spend on research and development?

$32.1 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does Alpha Tau Medical have?

$73.1 million in cash and short-term investments at Dec 31, 2025, per its 20-F.

Investor discussion: Alpha Tau Medical

Members talk about Alpha Tau Medical (DRTS). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Alpha Tau Medical, newest first. Each line links the filing it comes from.

Jun 3, 2026Financings
Reported a financing. SEC Form 6-K. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:DRTS on TradingView.

Listing details

Company: Alpha Tau Medical Ltd.
Ticker: DRTS
Listing: NASDAQ
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction